tradingkey.logo

Vyne Therapeutics Inc

VYNE
0.586USD
+0.001+0.21%
Close 12/19, 16:00ETQuotes delayed by 15 min
18.62MMarket Cap
LossP/E TTM

Vyne Therapeutics Inc Earnings Date

Period
FY2024 Earnings Date
Revenue(YoY)
501.00K
18.16%
EPS(YoY)
-0.94
66.23%
Analyst Rating
BUY
2025-12-09

Financial Indicators

EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Income Statement

Revenue
Operating profit
Net Profit
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Balance Sheet

Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Cash Flow Statement

Net operating income
Net investment
Net financing
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

FAQs

What is the total revenue of Vyne Therapeutics Inc?

According to Vyne Therapeutics Inc's FY2024 earnings report, its total revenue reached 501.00K, with a year-on-year change of 18.16%.

What is the Earnings Per Share (EPS) of Vyne Therapeutics Inc?

According to Vyne Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -0.935, with a year-on-year change of 66.23%.

What is the net income of Vyne Therapeutics Inc?

According to Vyne Therapeutics Inc's FY2024 earnings report, its net income was -39.83M, with a year-on-year change of -40.00%.

What is the net margin of Vyne Therapeutics Inc?

According to Vyne Therapeutics Inc's FY2024 earnings report, its net profit margin was -7945.51%, with a year-on-year change of -20.87%.

What is the gross margin of Vyne Therapeutics Inc?

According to Vyne Therapeutics Inc's FY2024 earnings report, its gross margin was 100.00%, with a year-on-year change of --.

What is the debt-to-asset ratio of Vyne Therapeutics Inc?

According to Vyne Therapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.

What is the Return on Equity (ROE) of Vyne Therapeutics Inc?

According to Vyne Therapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was -56.54%, with a year-on-year change of -21.64%.

What is the Return on Assets (ROA) of Vyne Therapeutics Inc?

According to Vyne Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was -48.37%, with a year-on-year change of -20.13%.

What is the operating profit of Vyne Therapeutics Inc?

According to Vyne Therapeutics Inc's FY2024 earnings report, its operating profit was -43.64M, with a year-on-year change of -49.15%.

What are the current assets of Vyne Therapeutics Inc?

According to Vyne Therapeutics Inc's FY2024 earnings report, its current assets were 64.44M, with a year-on-year change of -32.85%.

What are the total assets of Vyne Therapeutics Inc?

According to Vyne Therapeutics Inc's FY2024 earnings report, its total assets of Vyne Therapeutics Inc were 66.91M, with a year-on-year change of -31.51%.

What are the total liabilities of Vyne Therapeutics Inc?

According to Vyne Therapeutics Inc's FY2024 earnings report, its total liabilities of Vyne Therapeutics Inc were 14.82M, with a year-on-year change of 65.58%.

What is the total equity of Vyne Therapeutics Inc?

According to Vyne Therapeutics Inc's FY2024 earnings report, its total equity of Vyne Therapeutics Inc was 52.09M, with a year-on-year change of -41.30%.

What is the net operating income of Vyne Therapeutics Inc?

According to Vyne Therapeutics Inc's FY2024 earnings report, its net operating income of Vyne Therapeutics Inc was -39.81M, with a year-on-year change of -42.82%.

What is the net investment of Vyne Therapeutics Inc?

According to Vyne Therapeutics Inc's FY2024 earnings report, its net investment of Vyne Therapeutics Inc was 23.36M, with a year-on-year change of 140.74%.

What is the net financing of Vyne Therapeutics Inc?

According to Vyne Therapeutics Inc's FY2024 earnings report, its net financing of Vyne Therapeutics Inc was -141.00K, with a year-on-year change of -100.17%.
KeyAI